Research & Innovation 2021

Martin Everett

 Martin Everett
Martin Everett
CSO
Antabio
Speaker

Presentations at Research & Innovation 2021

Wed24  Feb03:40pm(30 mins)
Discovery and Development of Inhibitors of Pseudomonas Elastase as an Antivirulence Strategy to Treat Infections in CF Patients

Session: Innovative medicines: novel antimicrobials and microbiome interventions
Room: Workshop Room 1

Profile of Martin Everett

Martin has over 30 years’ experience in academia, pharmaceutical R&D (GSK) and biotechnology (MerLion, Antabio). At GSK he worked in anti-tubercular target development before managing an automated high-throughput screening group and leading several antibacterial and oncology lead discovery projects. At MerLion he was Head of Research leading a multi-disciplinary team discovering and developing novel natural product derived compounds and working on development of the fluoroquinolone antibiotic Finafloxacin. At Antabio, Martin is the CSO, leading the R&D team, and is PI for the PEI program funded by CARB-X.
Email
Please login to send a Private Message

Hosted By
ELRIG
The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Web Site Find us on Facebook Follow us on Twitter

Get the App
Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'
Eventflo Home
copyright ELRIG, eventflo, Labhoo Ltd 2003-2020